RESEARCH TRIANGLE PARK, NORTH CAROLINA--(Marketwire - December 10, 2008) - Adherex Technologies Inc. (TSX: AHX)(AMEX:ADH,), a biopharmaceutical company dedicated to solving problems for patients with cancer, today reported that it has received a notice from the NYSE Alternext US LLC, formerly the American Stock Exchange or AMEX (the “Exchange”), indicating that the Company does not meet certain of the continued listing requirements of the Exchange and, failing the submission of a plan of compliance by January 5, 2009, will be subject to delisting proceedings by the Exchange.
